ANGPTL3 and coronary artery disorder: Specifically, genetic epidemiological studies have demonstrated that ANGPTL3 loss of function is strongly associated with the lowering of circulating LDL-C, triglyceride-rich lipoproteins, and concurrent risk reduction in the development of CAD [16].